Reuters logo
BRIEF-Herantis Pharma granted U.S. patent on therapeutic use of MANF
May 23, 2017 / 6:31 AM / 4 months ago

BRIEF-Herantis Pharma granted U.S. patent on therapeutic use of MANF

May 23 (Reuters) - HERANTIS PHARMA OYJ

* REG-HERANTIS PHARMA GRANTED A U.S. PATENT ON THERAPEUTIC USE OF MANF

* UNITED STATES PATENT AND TRADEMARK OFFICE (“USPTO”) HAS ISSUED TO HERANTIS PHARMA PLC (“HERANTIS”) A PATENT TITLED “NEUROTROPHIC FACTOR MANF AND USES THEREOF” Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below